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Dear Editor, 
Poorly controlled diabetes mellitus can lead to blindness due to 
severe proliferative diabetic retinopathy. The pathophysiology 
of retinal involvement is important in diabetic retinopathy, with 
stress-induced cellular ion change and oxidation generally 
proposed to be the underlying mechanism [1 – 2]. Based on the 
concept of nanomedicine, it has been proven that there is no 
alteration in flux crossing the retina membrane in diabetes 
mellitus, so this cannot be the cause of retinopathy [3]. The 
author hereby proposed a new theory that there must also be 
an underlying problem in the cell directly. Indeed, retina cells 
also contain the protein, and this could be the attack point for 
hyperglycaemic bombardment. Applying the concept of energy 
fluctuation due to a high blood glucose-induced glycosylation 
process [4], the pathology of the retina might be explained. 
Indeed, the discovery of glycosylation processes in retinal cells 
has just been reported [5], which confirms the opinion of the 
energy fluctuation-induced retinal problems in poorly 
controlled diabetic cases [4]. This hypothesis could be justified 
by further basic clinical investigations. 
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